跳至主要内容
临床试验/JPRN-UMIN000007771
JPRN-UMIN000007771招募中2 期

Clinical study to evaluate the efficacy and safety of LH-RH agonist alternative therapy on prostate cancer patients who relapsed after combined androgen blockade. - Clinical study to evaluate the efficacy and safety of LH-RH agonist alternative therapy on prostate cancer patients who relapsed after combined androgen blockade.

Department of Urology, Ibaraki Prefecture Central Hospital0 个研究点目标入组 60 人开始时间: 2012年10月1日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 79years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1)Patients who have not observed anti-androgen withdrawal syndrome(AWS) 2)Treated with steroid drug 3)Undergone bilateral orchidectomy 4)Treated with chemotherapy 5)Treated with anti-androgen for benign prostate hyperplasia(BPH) 6)Considered inappropriate for this study by physicians

研究者

发起方
Department of Urology, Ibaraki Prefecture Central Hospital

相似试验